Business
Press Release Apr 08 2021
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 08, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 08, 2021, titled \"Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%\". View Attachment","length":465,"tagName":"div"}]